Literature DB >> 6381658

Neurological complications of Kaposi's sarcomat. An analysis of 5 cases and a review of the literature.

N W Barton, B Safai, S L Nielsen, J B Posner.   

Abstract

We analyzed the neurological complications in 25 patients with Kaposi's sarcoma, 5 encountered at Memorial Sloan-Kettering Cancer Center and 20 culled from the literature. Patients with all clinical forms of Kaposi's sarcoma [14 classical cases, 2 African cases, 5 cases associated with immunosuppressive therapy and 4 cases associated with acquired immunodeficiency syndrome (AIDS)] suffered neurological dysfunction which included neoplastic involvement of the nervous system (Kaposi's sarcoma or another primary), autoimmune disorders and opportunistic infections. Neoplastic involvement was recorded most frequently in patients with classical and African Kaposi's sarcoma and was favored in a setting of extensive tumor dissemination. Opportunistic infections (cryptococcal meningitis and cerebral toxoplasmosis) were observed in all forms of Kaposi's sarcoma but were most frequent in AIDS cases and correlated with the degree of immune dysfunction. Our data suggest that more diverse opportunistic central nervous system infections, neurological disorders of an autoimmune nature, and neoplastic involvement of the nervous system are to be anticipated in AIDS.

Entities:  

Mesh:

Year:  1983        PMID: 6381658     DOI: 10.1007/bf00165717

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  58 in total

1.  Immuno-hemolytic anemia in Kaposi's sarcoma with visceral involvement only.

Authors:  J MARTENSSON; H HENRIKSON
Journal:  Acta Med Scand       Date:  1954

2.  Neurological involvement in Kaposi's sarcoma.

Authors:  F Gonzalez-Crussi; A Mossanen; D M Robertson
Journal:  Can Med Assoc J       Date:  1969-03-08       Impact factor: 8.262

3.  Kaposi's sarcoma and toxoplasma gondii brain abscess in a Spanish homosexual.

Authors:  J Vilaseca; J M Arnau; R Bacardi; C Mieras; A Serrano; C Navarro
Journal:  Lancet       Date:  1982-03-06       Impact factor: 79.321

4.  Kaposi's sarcoma in homosexual men-a report of eight cases.

Authors:  K B Hymes; T Cheung; J B Greene; N S Prose; A Marcus; H Ballard; D C William; L J Laubenstein
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

5.  Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications.

Authors:  B Safai; V Miké; G Giraldo; E Beth; R A Good
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

6.  Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients.

Authors:  R S Brown; H A Haynes; H T Foley; H A Godwin; C W Berard; P P Carbone
Journal:  Ann Intern Med       Date:  1967-08       Impact factor: 25.391

7.  Association of Kaposi's sarcoma and prior immunosuppressive therapy: a 5-year material of Kaposi's sarcoma in Norway.

Authors:  O Klepp; O Dahl; J T Stenwig
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

8.  Autoimmune thrombocytopenic purpura in homosexual men.

Authors:  L Morris; A Distenfeld; E Amorosi; S Karpatkin
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

9.  Kaposi's sarcoma of the brain. A case report with necropsy findings.

Authors:  R J Rwomushana; I C Bailey; S K Kyalwazi
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

10.  Kaposi's sarcoma complicating corticosteroid therapy for temporal arteritis.

Authors:  F Leung; A G Fam; D Osoba
Journal:  Am J Med       Date:  1981-08       Impact factor: 4.965

View more
  2 in total

1.  Occurrence of Second Primary Malignancies in Patients With Primary Optic Nerve Gliomas: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Zain Hussain; Jawad Khan; Amir Saeed; Fatma Dihowm
Journal:  Cancer Diagn Progn       Date:  2021-11-03

Review 2.  Kaposi sarcoma in unusual locations.

Authors:  Liron Pantanowitz; Bruce J Dezube
Journal:  BMC Cancer       Date:  2008-07-07       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.